Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial

Objective To investigate whether dietary supplementation with docosahexaenoic acid (DHA) decreases liver fat content in children with non-alcoholic fatty liver disease (NAFLD). Design, setting and patients We performed a randomised controlled trial of DHA supplementation (250 and 500 mg/day) versus...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Archives of disease in childhood 2011-04, Vol.96 (4), p.350-353
Hauptverfasser:	Nobili, Valerio, Bedogni, Giorgio, Alisi, Anna, Pietrobattista, Andrea, Risé, Patrizia, Galli, Claudio, Agostoni, Carlo
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Alanine Transaminase - blood Biological and medical sciences Biopsy Body Composition Body mass index Care and treatment Child Demographic aspects Dietary Supplements Docosahexaenoic Acids - administration & dosage Docosahexaenoic Acids - blood Docosahexaenoic Acids - therapeutic use Dose-Response Relationship, Drug Double-Blind Method Drug dosages Fatty acids Fatty liver Fatty Liver - diagnostic imaging Fatty Liver - drug therapy Fatty Liver - metabolism Female Gastroenterology. Liver. Pancreas. Abdomen General aspects Glucose Grade 1 Grade 2 Health aspects Humans Insulin Insulin Resistance Liver Liver diseases Liver. Biliary tract. Portal circulation. Exocrine pancreas Male Medical sciences Miscellaneous Monte Carlo simulation Non-alcoholic Fatty Liver Disease Other diseases. Semiology Pediatrics Prevention and actions Public health. Hygiene Public health. Hygiene-occupational medicine Regression analysis Treatment Outcome Triglycerides Triglycerides - blood Ultrasonic imaging Ultrasonography Veins & arteries
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!